AstraZeneca PLC (AZN) annual results, year to 31 December 2018: revenue USD 22,090 million, from the 20-F
AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2018 it reported revenue of USD 22,090 million, down 1.7% on the year before. Its profit attributable to shareholders was USD 2,155 million, down 28.2%, and diluted earnings per share USD 1.70.
this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.
Income statement (profit and loss)
| Year to | Dec 2017 | Dec 2018 |
|---|---|---|
| Revenue | 22,465 | 22,090 |
| Cost of sales | 4,318 | 4,936 |
| Gross profit | 18,147 | 17,154 |
| Research and development | 5,757 | 5,932 |
| Selling, general and administrative | 10,233 | 10,031 |
| Operating profit | 3,677 | 3,387 |
| Finance costs | 1,508 | 1,419 |
| Profit before tax | 2,227 | 1,993 |
| Income tax | -641 | -57.0 |
| Profit for the year | 2,868 | 2,050 |
| Profit attributable to shareholders | 3,001 | 2,155 |
| Filing | 20-F | 20-F |
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read more
A line the company does not file under the standard tag is left out rather than estimated.USD per ordinary share, as filed.
Cash flow
| Year to | Dec 2017 | Dec 2018 |
|---|---|---|
| Cash from operations | 3,578 | 2,618 |
| Purchase of property, plant and equipment | 1,326 | 1,043 |
| Free cash flow | 2,252 | 1,575 |
| Cash from investing | -2,328 | 963 |
| Cash from financing | -2,936 | -2,044 |
| Dividends paid | 3,519 | 3,484 |
| Filing | 20-F | 20-F |
USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.
Balance sheet
| Year to | Dec 2017 | Dec 2018 |
|---|---|---|
| Funded by | ||
| Equity attributable to shareholders | 14,960 | 12,468 |
| Non-controlling interests | 1,682 | 1,576 |
| Borrowings, as filed | 17,807 | 19,113 |
| Other liabilities | 28,905 | 27,494 |
| Total equity and liabilities | 63,354 | 60,651 |
| Owned | ||
| Property, plant and equipment | 7,615 | 7,421 |
| Goodwill | 11,825 | 11,707 |
| Other intangible assets | 26,188 | 21,959 |
| Cash and cash equivalents | 3,324 | 4,831 |
| Trade and other receivables | 5,009 | 5,574 |
| Inventories | 3,035 | 2,890 |
| Other assets | 6,358 | 6,269 |
| Total assets | 63,354 | 60,651 |
| Filing | 20-F | 20-F |
USD million, at each fiscal year end.
Ratios on the filed lines
| Year to | Dec 2017 | Dec 2018 |
|---|---|---|
| Gross margin | 80.8% | 77.7% |
| Operating margin | 16.4% | 15.3% |
| Net margin | 13.4% | 9.8% |
| Free cash flow margin | 10.0% | 7.1% |
| Return on year-end equity | 20.1% | 17.3% |
| Effective tax rate | -28.8% | -2.9% |
| Filing | 20-F | 20-F |
Arithmetic on the filed lines of the same year.
20-F for the year to 31 December 2018, filed 16 February 2021: the filing. The figures are in US dollars as filed.